Evidence map›Paper›PMID 41746484›Full record

SynthesisThe international journal of cardiovascular imaging2026

Prognostic value of left atrial function in cardiac amyloidosis: a systematic review and meta‑analysis.

Felicia María García Méndez, Carlos Fonseca-Marrero, Ismael Sosa González, Aylen Pérez Barreda, José Antonio Roldán-Nofuentes, José Alejandro Ávila Cabreja

Abstract readSystematic ReviewMeta-Analysis
PubMed Publisher
In one paragraph

Synthesis in The international journal of cardiovascular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Felicia María García MéndezSchool of Medicine, University of Granada, Ave. Doctor Jesús Candel Fábregas 11, 18016, Granada, Spain. garciamendez@correo.ugr.es.ORCID http://orcid.org/0000-0002-5965-0425
Carlos Fonseca-MarreroInstituto de Cardiología y Cirugía Cardiovascular, Havana, Cuba.ORCID http://orcid.org/0000-0001-7382-2812
Ismael Sosa GonzálezCentro Médico Asunción Doce, Seville, Spain.ORCID http://orcid.org/0000-0002-8417-4029
Aylen Pérez BarredaInstituto de Cardiología y Cirugía Cardiovascular, Havana, Cuba.ORCID http://orcid.org/0000-0001-9990-9844
José Antonio Roldán-NofuentesSchool of Medicine, University of Granada, Ave. Doctor Jesús Candel Fábregas 11, 18016, Granada, Spain.ORCID http://orcid.org/0000-0003-0251-5588
José Alejandro Ávila CabrejaInstituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.ORCID http://orcid.org/0000-0003-0900-2101

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To evaluate the prognostic value of left atrial (LA) function parameters, assessed by echocardiography or cardiac magnetic resonance, in patients with cardiac amyloidosis. We conducted a systematic review and meta-analysis of cohort studies evaluating the prognostic role of LA function parameters, such as left atrial reservoir strain (LASr), in confirmed light-chain amyloid cardiomyopathy (AL-CM) or transthyretin amyloid cardiomyopathy (ATTR-CM). Twenty studies were included, comprising a total of 3,260 participants. LASr was inversely associated with all-cause mortality (HR: 0.92; 95% CI: 0.88-0.96), although with low certainty of evidence. LASr was also associated with a lower risk of atrial fibrillation (HR: 0.92; 95% CI: 0.88-0.96), likewise with low certainty. Contractile strain was associated with reduced all-cause mortality (HR: 0.83; 95% CI: 0.76-0.91). The LA stiffness index was associated with increased all-cause mortality (HR: 1.17; 95% CI: 1.09-1.26). Other parameters also showed associations with all-cause mortality; however, the number of available studies was insufficient. In patients with cardiac amyloidosis, assessment of LA function provides incremental prognostic information beyond ventricular parameters for identifying individuals at higher risk of adverse clinical outcomes. Nevertheless, the certainty of the evidence is low or very low, which does not support its routine prognostic use.

Indexed as

Amyloid Neuropathies, FamilialAtrial Function, LeftCardiomyopathiesImmunoglobulin Light-chain AmyloidosisAgedAged, 80 and overAtrial FibrillationBiomechanical PhenomenaEchocardiographyFemaleHeart AtriaHumansMaleMiddle AgedPredictive Value of TestsPrognosisAmyloidosisImmunoglobulin light-chain amyloidosisLeft atrial functionMeta-analysisPrognosis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.